Capital Goods Healthcare Sector

Omeros

Market Cap: US$192.8m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.

SOPHiA GENETICS

Market Cap: US$192.4m

Operates as a cloud-native software technology company in the healthcare space.

Tonix Pharmaceuticals Holding

Market Cap: US$192.4m

A biopharmaceutical company, focuses on developing and commercializing therapeutics to treat and prevent human disease.

Y-mAbs Therapeutics

Market Cap: US$191.5m

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of radioimmunotherapy and antibody based therapeutic products for the treatment of cancer.

Orthocell

Market Cap: AU$296.4m

A regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia, the United States, the United Kingdom, and the European Union.

High Tide

Market Cap: CA$263.9m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Inhibrx Biosciences

Market Cap: US$189.2m

A clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions.

CARGO Therapeutics

Market Cap: US$189.1m

A clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients.

OmniAb

Market Cap: US$188.4m

A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.

Voyager Therapeutics

Market Cap: US$188.1m

A biotechnology company, focuses on the human genetics for the cure of neurological diseases.

Electromed

Market Cap: US$186.3m

Develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally.

ProQR Therapeutics

Market Cap: US$185.4m

A biotechnology company, focuses on the discovery and development of novel therapeutic medicines.

Pacific Smiles Group

Market Cap: AU$286.9m

Owns and operates dental centers under the Pacific Smiles Dental Centres and Nib Dental Care Centres names in Australia.

Eledon Pharmaceuticals

Market Cap: US$183.2m

Operates as a clinical stage biotechnology company.

CVRx

Market Cap: US$182.2m

A commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally.

Organigram Global

Market Cap: CA$251.7m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

Baird Medical Investment Holdings

Market Cap: US$180.7m

Engages in research and development, manufacturing, and sales of microwave ablation and other medical devices in the People’s Republic of China.

Deltex Medical Group

Market Cap: US$180.6m

Manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, and internationally.

Puma Biotechnology

Market Cap: US$180.2m

A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.

Esperion Therapeutics

Market Cap: US$180.1m

A pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States.

Stereotaxis

Market Cap: US$179.7m

Designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.

Accuray

Market Cap: US$179.2m

Designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China.

4D Molecular Therapeutics

Market Cap: US$178.3m

A late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.

INmune Bio

Market Cap: US$178.3m

A clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States.

DiaMedica Therapeutics

Market Cap: US$177.2m

A clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases.

AVITA Medical

Market Cap: US$177.1m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

SELLAS Life Sciences Group

Market Cap: US$176.2m

A late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States.

Utah Medical Products

Market Cap: US$176.1m

Provides medical devices for the healthcare industry worldwide.

scPharmaceuticals

Market Cap: US$173.7m

A pharmaceutical company, focuses on developing and commercializing products to optimize the delivery of infused therapies and patient care.

TriSalus Life Sciences

Market Cap: US$173.3m

Engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers.

AC Immune

Market Cap: US$173.2m

A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.

Anika Therapeutics

Market Cap: US$171.5m

A joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.

Spectral Medical

Market Cap: CA$236.6m

Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.

Alpha Cognition

Market Cap: US$169.4m

A biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada.

Sight Sciences

Market Cap: US$169.1m

An ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases.

Inogen

Market Cap: US$168.6m

A medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally.